Only Hoover's leverages journalistic capabilities to transform company research into easy-to-read, entertaining content.
Company Research: XTENT Corporate Information
Contact this company: 650-475-9400
Need in-depth company research? Need comprehensive XTENT corporate information? Similar to the company research that Hoover's provides for all public companies, the XTENT profile created by Hoover's in-house editorial team includes full financials, supplemented with company research on its operations, ownership, and past strategies. The XTENT Overview and History provide an historical perspective of how XTENT has evolved.
XTENT Corporate Information
XTENT aims to ensure that your heart will go on. The development-stage firm designs drug-coated stents that treat coronary artery disease. The stents prop open clogged arteries and emit an anti-inflammatory drug called Biolimus A9 that keeps the blood vessel from re-closing once the procedure is done. Unlike other stent...
Hoover's supplements secondary sources with primary research conducted by an in-house editorial team. XTENT corporate information also includes details on XTENT executives, products and operations, and family tree. With Hoover's, you can take advantage of proprietary company research on more than 28 million businesses.
See how you can view all of Hoover's company research for XTENT.
